Data as of Mar 13
| -7.50 / -2.21%|
The 24 analysts offering 12-month price forecasts for Biogen Idec Inc have a median target of 351.50, with a high estimate of 422.00 and a low estimate of 262.00. The median estimate represents a +5.86% increase from the last price of 332.05.
The current consensus among 29 polled investment analysts is to Buy stock in Biogen Idec Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.